Skip links

Miglustat

Full Name miglustat
Drug Miglustat
Manufacturer Generic
Route of Administration Oral
Site of Care Home or Healthcare Facility
Approved Indication Monotherapy for treatment of adult patients with mild/moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option
Disease Gaucher Type I Disease
Therapeutic Area Neurology, Genetics
Enrollment Form Link Miglustat Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581